An early economic analysis of medical cannabis for the treatment of chronic pain
These findings highlight the substantial cost saving that CBMPs may represent for the treatment of chronic pain patients, and the benefits for healthcare providers as a treatment for this often hard-to-treat population.
Authors
- Michael T. Lynskey (ORCID: https://orcid.org/0000-0001-9989-737X)
- Shanna Marrinan (ORCID: https://orcid.org/0000-0003-1310-7838)
- Callie Seaman (ORCID: https://orcid.org/0000-0001-6298-6029)
- Anne Katrin Schlag (ORCID: https://orcid.org/0000-0003-2074-1917)
- David Nutt (ORCID: https://orcid.org/0000-0002-6423-9411)
- Michael P. Barnes
- Mike Morgan-Giles
Institutions
- Committee on Climate Change (GB)
- Imperial College London (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1080/14737167.2024.2412248
- Citations
- 2
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.90